IGNYTA, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 99 rows, 99 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-02-08: Reporting owner Start Valerie Denise Harding; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-02-08: Reporting owner Start Valerie Denise Harding; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-02-08: Reporting owner Multani Pratik S; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-02-08: Reporting owner Multani Pratik S; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-02-08 | Start Valerie Denise Harding Officer (SVP, Chemistry, Mfg & Controls) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $14.47 exercise price | 2018-02-12 | |
| 2018-02-08 | Start Valerie Denise Harding Officer (SVP, Chemistry, Mfg & Controls) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $5.60 exercise price | 2018-02-12 | |
| 2018-02-08 | Multani Pratik S Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $6.90 exercise price | 2018-02-12 | |
| 2018-02-08 | Multani Pratik S Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $5.60 exercise price | 2018-02-12 | |
| 2018-02-08 | McCarthy William R Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $13.29 exercise price | 2018-02-12 | |
| 2018-02-08 | McCarthy William R Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $5.60 exercise price | 2018-02-12 | |
| 2018-02-08 | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −400,000 0 owned after | $6.00 exercise price | 2018-02-12 | |
| 2018-02-08 | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −100,000 0 owned after | $6.58 exercise price | 2018-02-12 | |
| 2018-02-08 | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −120,000 0 owned after | $5.60 exercise price | 2018-02-12 | |
| 2018-02-08 | Kuhlen Christian V Officer (General Counsel and Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −160,000 0 owned after | $5.70 exercise price | 2018-02-12 | |
| 2018-02-08 | Kuhlen Christian V Officer (General Counsel and Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $5.60 exercise price | 2018-02-12 | |
| 2018-02-08 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,000 0 owned after | $1.02 exercise price | 2018-02-12 | |
| 2018-02-08 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −250,000 0 owned after | $6.00 exercise price | 2018-02-12 | |
| 2018-02-08 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −48,000 0 owned after | $6.58 exercise price | 2018-02-12 | |
| 2018-02-08 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −60,000 0 owned after | $5.60 exercise price | 2018-02-12 | |
| 2018-02-08 | Hoerter Steven L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $6.40 exercise price | 2018-02-12 | |
| 2018-02-08 | Hoerter Steven L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,666 0 owned after | $8.35 exercise price | 2018-02-12 | |
| 2018-02-08 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,666 0 owned after | $1.02 exercise price | 2018-02-12 | |
| 2018-02-08 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $8.95 exercise price | 2018-02-12 | |
| 2018-02-08 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,000 0 owned after | $7.59 exercise price | 2018-02-12 | |
| 2018-02-08 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $5.75 exercise price | 2018-02-12 | |
| 2018-02-08 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,000 0 owned after | $8.35 exercise price | 2018-02-12 | |
| 2018-02-08 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,666 0 owned after | $0.18 exercise price | 2018-02-12 | |
| 2018-02-08 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $1.02 exercise price | 2018-02-12 | |
| 2018-02-08 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $6.00 exercise price | 2018-02-12 | |
| 2018-02-08 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $6.76 exercise price | 2018-02-12 | |
| 2018-02-08 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $5.75 exercise price | 2018-02-12 | |
| 2018-02-08 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,000 0 owned after | $8.35 exercise price | 2018-02-12 | |
| 2018-02-08 | Chacko Jacob Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −250,000 0 owned after | $7.40 exercise price | 2018-02-12 | |
| 2018-02-08 | Chacko Jacob Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,200 0 owned after | $6.58 exercise price | 2018-02-12 | |
| 2018-02-08 | Chacko Jacob Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −50,000 0 owned after | $5.60 exercise price | 2018-02-12 | |
| 2018-02-08 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,666 0 owned after | $0.57 exercise price | 2018-02-12 | |
| 2018-02-08 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $1.02 exercise price | 2018-02-12 | |
| 2018-02-08 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $6.00 exercise price | 2018-02-12 | |
| 2018-02-08 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $6.76 exercise price | 2018-02-12 | |
| 2018-02-08 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $5.75 exercise price | 2018-02-12 | |
| 2018-02-08 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,000 0 owned after | $8.35 exercise price | 2018-02-12 | |
| 2018-02-08 | Bristol James A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,000 0 owned after | $8.95 exercise price | 2018-02-12 | |
| 2018-02-08 | Bristol James A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $5.75 exercise price | 2018-02-12 | |
| 2018-02-08 | Bristol James A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,000 0 owned after | $8.35 exercise price | 2018-02-12 | |
| 2017-06-13 | Hoerter Steven L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,666 11,666 owned after | $8.35 exercise price | 2017-06-19 | |
| 2017-06-13 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.35 exercise price | 2017-06-19 | |
| 2017-06-13 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.35 exercise price | 2017-06-19 | |
| 2017-06-13 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.35 exercise price | 2017-06-19 | |
| 2017-06-13 | Bristol James A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $8.35 exercise price | 2017-06-19 | |
| 2017-05-03 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,083 0 owned after | $0.57 exercise price | 2017-05-05 | |
| 2017-05-03 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,389 0 owned after | $0.60 exercise price | 2017-05-05 | |
| 2017-05-03 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 40,000 owned after | $1.02 exercise price | 2017-05-05 | |
| 2017-02-13 | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,945 0 owned after | $0.60 exercise price | 2017-03-10 | |
| 2017-01-05 | Start Valerie Denise Harding Officer (SVP, Chemistry, Mfg & Controls) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $5.60 exercise price | 2017-01-06 | |
| 2017-01-05 | Multani Pratik S Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $5.60 exercise price | 2017-01-06 | |
| 2017-01-05 | McCarthy William R Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $5.60 exercise price | 2017-01-06 | |
| 2017-01-05 | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +120,000 120,000 owned after | $5.60 exercise price | 2017-01-06 | |
| 2017-01-05 | Kuhlen Christian V Officer (General Counsel and Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $5.60 exercise price | 2017-01-06 | |
| 2017-01-05 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $5.60 exercise price | 2017-01-06 | |
| 2017-01-05 | Chacko Jacob Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $5.60 exercise price | 2017-01-06 | |
| 2016-12-08 | Hoerter Steven L. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $6.40 exercise price | 2016-12-09 | |
| 2016-07-05 | Kuhlen Christian V Officer (General Counsel and Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +160,000 160,000 owned after | $5.70 exercise price | 2016-07-06 | |
| 2016-06-13 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.75 exercise price | 2016-06-15 | |
| 2016-06-13 | Bristol James A Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.75 exercise price | 2016-06-15 | |
| 2016-06-13 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.75 exercise price | 2016-06-15 | |
| 2016-06-13 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $5.75 exercise price | 2016-06-15 | |
| 2016-04-11 | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,388 6,945 owned after | $0.60 exercise price | 2016-04-13 | |
| 2016-03-17 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,917 2,083 owned after | $0.57 exercise price | 2016-04-13 | |
| 2016-03-17 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,277 1,389 owned after | $0.60 exercise price | 2016-04-13 | |
| 2016-03-10 | Casdin Alexander W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $6.76 exercise price | 2016-03-11 | |
| 2016-03-10 | Dreismann Heiner Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $6.76 exercise price | 2016-03-11 | |
| 2015-12-07 | McCarthy William R Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $13.29 exercise price | 2015-12-07 | |
| 2015-09-17 | BILINSKY IGOR Officer (GM, Immuno-Oncology/SVP Sp Ops) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $16.75 exercise price | 2015-09-17 | |
| 2015-09-02 | Start Valerie Denise Harding Officer (SVP, Chemistry, Mfg & Controls) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $14.47 exercise price | 2015-09-02 | |
| 2015-07-22 | Parker Bernard Officer (Chief Commercial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $16.31 exercise price | 2015-07-22 | |
| 2015-02-17 | Multani Pratik S Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $6.90 exercise price | 2015-02-17 | |
| 2015-01-08 | Onaitis Matthew Officer (General Counsel and Secretary) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,160 44,160 owned after | $6.58 exercise price | 2015-01-09 | |
| 2015-01-08 | Senderowicz Adrian Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,400 8,400 owned after | $6.58 exercise price | 2015-01-09 | |
| 2015-01-08 | WILD ROBERT Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,200 13,200 owned after | $6.58 exercise price | 2015-01-09 | |
| 2015-01-08 | Hornby Zachary Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,000 48,000 owned after | $6.58 exercise price | 2015-01-09 | |
| 2015-01-08 | Chacko Jacob Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,200 25,200 owned after | $6.58 exercise price | 2015-01-09 | |
| 2015-01-08 | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $6.58 exercise price | 2015-01-09 | |
| 2014-09-08 | WILD ROBERT Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $7.90 exercise price | 2014-09-08 | |
| 2014-08-11 | Freddo James L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 5,000 owned after | $7.59 exercise price | 2014-08-11 | |
| 2014-08-11 | Senderowicz Adrian Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $7.59 exercise price | 2014-08-11 | |
| 2014-05-30 | Chacko Jacob Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $7.40 exercise price | 2014-05-30 | |
| 2014-03-13 holding as of filing | Freddo James L Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.02 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Freddo James L Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.95 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Dreismann Heiner Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.18 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Dreismann Heiner Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.02 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Dreismann Heiner Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.00 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Casdin Alexander W. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.57 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Casdin Alexander W. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.02 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Casdin Alexander W. Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.00 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Bristol James A Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.95 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Onaitis Matthew Officer (General Counsel and Secretary) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.95 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Zaknoen Sara Officer (Chief Medical Officer) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $8.95 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Hornby Zachary Officer (CFO and VP, Corp. Development) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.57 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Hornby Zachary Officer (CFO and VP, Corp. Development) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.60 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Hornby Zachary Officer (CFO and VP, Corp. Development) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $1.02 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Hornby Zachary Officer (CFO and VP, Corp. Development) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.00 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $0.60 exercise price | 2014-03-13 | ||
| 2014-03-13 holding as of filing | Lim Jonathan E Director, Officer (President, CEO & Director), 10% Owner | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.00 exercise price | 2014-03-13 |